BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10618942)

  • 1. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study.
    van den Broek WW; Leentjens AF; Mulder PG; Kusuma A; Bruijn JA
    Br J Anaesth; 1999 Aug; 83(2):271-4. PubMed ID: 10618942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT.
    McCall WV; Zvara D; Brooker R; Arias L
    Convuls Ther; 1997 Sep; 13(3):175-80. PubMed ID: 9342133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation.
    Howie MB; Hiestand DC; Zvara DA; Kim PY; McSweeney TD; Coffman JA
    Anesth Analg; 1992 Nov; 75(5):805-10. PubMed ID: 1358003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy.
    Kovac AL; Goto H; Arakawa K; Pardo MP
    Can J Anaesth; 1990 Jan; 37(1):58-62. PubMed ID: 1967227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of diltiazem on hemodynamics and seizure duration during electroconvulsive therapy.
    Wajima Z; Yoshikawa T; Ogura A; Imanaga K; Shiga T; Inoue T; Ogawa R
    Anesth Analg; 2001 May; 92(5):1327-30. PubMed ID: 11323371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy.
    Kovac AL; Goto H; Pardo MP; Arakawa K
    Can J Anaesth; 1991 Mar; 38(2):204-9. PubMed ID: 1673645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy.
    Zvara DA; Brooker RF; McCall WV; Foreman AS; Hewitt C; Murphy BA; Royster RL
    Convuls Ther; 1997 Sep; 13(3):165-74. PubMed ID: 9342132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-blockers and electroconvulsive therapy: a review].
    van den Broek WW; Groenland TH; Mulder PG; Kusuma A; Birkenhäger TK; Pluijms EM; Bruijn JA
    Tijdschr Psychiatr; 2008; 50(4):205-15. PubMed ID: 18398800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of four pretreatment regimes on hemodynamics during electroconvulsive therapy: A double-blind randomized controlled crossover trial.
    Parikh DA; Garg SN; Dalvi NP; Surana PP; Sannakki D; Tendolkar BA
    Ann Card Anaesth; 2017; 20(1):93-99. PubMed ID: 28074804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a single dose of esmolol on the bispectral index scale (BIS) during propofol/fentanyl anaesthesia.
    Berkenstadt H; Loebstein R; Faibishenko I; Halkin H; Keidan I; Perel A
    Br J Anaesth; 2002 Sep; 89(3):509-11. PubMed ID: 12402733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy.
    Howie MB; Black HA; Zvara D; McSweeney TD; Martin DJ; Coffman JA
    Anesth Analg; 1990 Oct; 71(4):384-8. PubMed ID: 1975995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intravenous lignocaine on haemodynamics and seizure duration during electroconvulsive therapy.
    Wajima Z; Yoshikawa T; Ogura A; Shiga T; Inoue T; Ogawa R
    Anaesth Intensive Care; 2002 Dec; 30(6):742-6. PubMed ID: 12500511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of esmolol and labetalol to attenuate haemodynamic responses after electroconvulsive therapy.
    Shrestha S; Shrestha BR; Thapa C; Pradhan SN; Thapa R; Adhikari S
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):318-23. PubMed ID: 18604047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hemodynamic effects of dexmedetomidine and esmolol in electroconvulsive therapy: a retrospective comparison.
    Aydogan MS; Yücel A; Begec Z; Colak YZ; Durmus M
    J ECT; 2013 Dec; 29(4):308-11. PubMed ID: 23774056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
    Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N
    Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics.
    Weinger MB; Partridge BL; Hauger R; Mirow A
    Anesth Analg; 1991 Nov; 73(5):556-62. PubMed ID: 1952135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind placebo controlled study of the effects of etomidate-alfentanil anesthesia in electroconvulsive therapy.
    van den Broek WW; Groenland TH; Kusuma A; Mulder PG; Bruijn JA
    J ECT; 2004 Jun; 20(2):107-11. PubMed ID: 15167427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative use of bolus doses of esmolol to treat tachycardia.
    Kanitz DD; Ebert TJ; Kampine JP
    J Clin Anesth; 1990; 2(4):238-42. PubMed ID: 1975188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dose-related effects of bolus esmolol on heart rate and blood pressure following laryngoscopy and intubation.
    Bensky KP; Donahue-Spencer L; Hertz GE; Anderson MT; James R
    AANA J; 2000 Oct; 68(5):437-42. PubMed ID: 11759128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory responses during electroconvulsive therapy. The comparative effects of placebo, esmolol and nitroglycerin.
    O'Flaherty D; Husain MM; Moore M; Wolff TR; Sills S; Giesecke AH
    Anaesthesia; 1992 Jul; 47(7):563-7. PubMed ID: 1352662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.